Halogen bonds were first proposed as an activating interaction in 2008, but this alternative type of organocatalysis was ...
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback